1例肝性脑病营养支持实施的病例报道

关珂; 杨婷婷; 杨阳; 王雯; 王卫香; 陈永春

doi:10.16766/j.cnki.issn.1674-4152.001803

1例肝性脑病营养支持实施的病例报道

doi: 10.16766/j.cnki.issn.1674-4152.001803

河南省人民医院营养科，河南郑州 450000

详细信息

通讯作者:
陈永春，E-mail：13703861623@163.com

中图分类号: R575.3 R459.3
计量
- 文章访问数: 66
- HTML全文浏览量: 31
- PDF下载量: 11
- 被引次数: 0
出版历程
- 收稿日期: 2020-03-28
- 网络出版日期: 2022-02-19

摘要

- 肝性脑病 /
- 营养支持 /
- 肠内营养

HTML全文

图 1 患者白蛋白及血红蛋白水平

下载: 全尺寸图片幻灯片

图 2 患者前白蛋白水平

下载: 全尺寸图片幻灯片

图 3 患者转氨酶及血氨水平

下载: 全尺寸图片幻灯片

图 4 患者胆红素水平

下载: 全尺寸图片幻灯片

参考文献(20)

[1]	徐小元, 丁惠国, 李文刚, 等. 肝硬化肝性脑病诊疗指南(2018年, 北京)[J]. 中华胃肠内镜电子杂志, 2018, 5(3): 97-113. https://www.cnki.com.cn/Article/CJFDTOTAL-WCNJ201803001.htm
[2]	KRISHNARAO A, GORDON F D. Prognosis of hepatic encephalopathy[J]. Clin Liver Dis, 2020, 24(2): 219-229. doi: 10.1016/j.cld.2020.01.004
[3]	MERLI M, BERZIGOTTI A, ZELBER-SAGI S, et al. EASL Clinical practice guidelines on nutrition in chronic liver disease[J]. J Hepatol, 2019, 70(1): 172-193 doi: 10.1016/j.jhep.2018.06.024
[4]	侯昀. 肝硬化不同病因上消化道出血患者的临床对比[J]. 临床和实验医学杂志, 2015, 14(12): 999-1001. doi: 10.3969/j.issn.1671-4695.2015.012.014
[5]	FALLAHZADEH M A, RAHIMI R S. Hepatic encephalopathy and nutrition influences: A narrative review[J]. Nutr Clin Pract, 2020, 35(1): 36-48. doi: 10.1002/ncp.10458
[6]	MOCTEZUMA-VELAZQUEZ C, EBADI M, BHANJI R A, et al. Limited performance of subjective global assessment compared to computed tomography-determined sarcopenia in predicting adverse clinical outcomes in patients with cirrhosis[J]. Clin Nutr, 2019, 38(6): 2696-2703. doi: 10.1016/j.clnu.2018.11.024
[7]	MCCLAVE S A, TAYLOR B E, MARTINDALE R G, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition(A.S.P.E.N. )[J]. Jpen-Parenter Enter, 2016, 40(2): 159-211. doi: 10.1177/0148607115621863
[8]	SINGER P, BLASER A R, BERGER M M, et al. ESPEN guideline on clinical nutrition in the intensive care unit[J]. Clin Nutr, 2019, 38(1): 48-79. doi: 10.1016/j.clnu.2018.08.037
[9]	孙仁华, 江荣林, 黄曼. 重症患者早期肠内营养临床实践专家共识[J]. 中华危重病急救医学, 2018, 30(8): 715-721.
[10]	REINTAM BLASER A, STARKOPF J, ALHAZZANI W, et al. Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines[J]. Intens Care Med, 2017, 43(3): 380-398. doi: 10.1007/s00134-016-4665-0
[11]	LI Y, ZHUANG S T, YANG M, et al. Bio-statistical analysis of early supplementary parenteral nutrition in critically ill patients[J]. J Med Imag Health In, 2019, 9(5): 940-944. http://www.ingentaconnect.com/contentone/asp/jmihi/2019/00000009/00000005/art00014
[12]	GUNST J, VAN DEN BERGHE G. Parenteral nutrition in the critically ill[J]. Curr Opin Crit Care, 2017, 23(2): 149-158. doi: 10.1097/MCC.0000000000000385
[13]	CHEN C J, WANG L C, KUO H T, et al. Significant effects of late evening snack on liver functions in patients with liver cirrhosis: A meta-analysis of randomized controlled trials[J]. J Gastroen Hepatol, 2019, 34(7): 1143-1152. doi: 10.1111/jgh.14665
[14]	KORNERUP L S, GLUUD L L, VILSTRU H, et al. Update on the therapeutic management of hepatic encephalopathy[J]. Curr Gastroenterol Rep, 2018, 20(5): 21-32. doi: 10.1007/s11894-018-0627-8
[15]	GLUUD L L, DAM G B, METTE L, et al. Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials1, 2[J]. J Nutr, 2013, 143(8): 1263-1268. doi: 10.3945/jn.113.174375
[16]	GLUUD L L, DAM G, LES I, et al. Branched-chain amino acids for people with hepatic encephalopathy[J]. Cochrane Database Syst Rev, 2017, 5: 1939-1946. http://www.researchgate.net/profile/Gitte_Dam/publication/272838852_Branched-chain_amino_acids_for_people_with_hepatic_encephalopathy/links/54f414760cf24eb8794d26a5.pdf
[17]	SIMON-TALERO M, GARCIA-MARTINEZ R, TORRENS M, et al. Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study[J]. J Hepatol, 2013, 59(6): 1184-1192. doi: 10.1016/j.jhep.2013.07.020
[18]	ZUCKER D M, REDULLA R. Lactulose management of minimal hepatic encephalopathy: a systematic review[J]. Gastroenterol Nurs, 2019, 42(1): 84-94. doi: 10.1097/SGA.0000000000000429
[19]	SHARMA B C, SINGH J. Probiotics in management of hepatic encephalopathy[J]. Metab Brain Dis, 2016, 31(6): 1295-1301. doi: 10.1007/s11011-016-9826-x
[20]	WEIR V, REDDY K R. Nonpharmacologic management of hepatic encephalopathy: an update[J]. Clin liver Dis, 2020, 24(2): 243-261. doi: 10.1016/j.cld.2020.01.003